Viewing Study NCT05689801



Ignite Creation Date: 2024-05-06 @ 6:30 PM
Last Modification Date: 2024-10-26 @ 2:49 PM
Study NCT ID: NCT05689801
Status: RECRUITING
Last Update Posted: 2023-01-19
First Post: 2022-12-22

Brief Title: Describe the Effect of the Optimized Hemodialysis Technique HDx With Medium Cut-Off Membrane on Recovery Time and Quality of Life
Sponsor: Ramsay Générale de Santé
Organization: Ramsay Générale de Santé

Study Overview

Official Title: Pilot Study Describe the Effect of the Optimized Hemodialysis Technique HDx With Medium Cut-Off Membrane on Recovery Time and Quality of Life
Status: RECRUITING
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EHDXTRQV
Brief Summary: In this study the effect of optimizing the dialytic technique using simple questionnaires carried out in clinical routine will be described

More specifically the conventional dialysis technique will be combined with biofeedback software called HemoControl The recovery time and quality of life of patients who will use a polyethersulfone membrane Revaclear and a Medium Cut-Off MCO membrane Theranova will be observed

The main objective is to describe the evolution of recovery time after a dialysis session in conventional hemodialysis HD on Revaclear membrane and in so-called optimized hemodialysis HDx on MCO membrane Theranova
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None